---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000821"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:29:06.151408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Oncotelic lowers CEO milestone threshold from $100M to $45M market cap for stock vesting

## Summary
- Amendment reduces first market cap milestone for CEO Vuong Trieu's restricted stock from $100M to $45M.
- Similar amendment with Jefferson Capital Ventures LLC lowers its milestone threshold to $45M.
- Company states changes are to support progress including equity line with Mast Hills and uplisting efforts.
- Other terms and milestones of the restricted stock agreements remain unchanged.
- CEO's preferred stock award is tied to the same reduced milestone; no dilution details provided.

## SEC filing metadata
- accession: 0001493152-26-000821
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315226000821/0001493152-26-000821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315226000821/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000821
- JSON: https://secwatch.observer/filing/0001493152-26-000821.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.